After reports of dispensing errors involving these two drugs with similar-sounding names, the Food and Drug Administration worked with pharmaceutical manufacturers to change the name of Kapidex. Kapidex is used in the treatment of acid reflux, while Casodex is prescribed for prostate cancer patients. The manufacturer, Takeda Pharmaceuticals, announced on March 4, 2010, that Kapidex would be renamed Dexilant to avoid future confusion with Casodex. (ABC News)